Stock Events

Stock Events

Amylyx Pharmaceuticals (AMLX) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.07

-0.85

-0.64

-0.42

Details

Expected EPS

-0.475

Actual EPS

-0.42

Surprise EPS

0.05

Surprise Percent

+11.58%

Description

Amylyx Pharmaceuticals (AMLX) has reported earnings of -0.42 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.